Variantyx · raw details

Advanced Genomic Diagnostic Solutions · Tel Aviv-Yafo · Founded 2014

active Series D ← back to profile

Highlights

1 patentProfile claimed by owner

About

Advanced Genomic Diagnostic Solutions

Variantyx is an award-winning, technology-driven molecular diagnostics lab that offers innovative solutions in the genetic disorders, reproductive health, and precision oncology markets. Its proprietary whole genome analysis platform provides unparalleled diagnostic capabilities, enhances personalized treatment recommendations, shortens the time to diagnosis, and reduces healthcare costs.

The company offers a wide variety of test options, ranging from targeted to comprehensive analyses. Targeted analyses focus on pre-curated panels of indication-relevant genes while comprehensive analyses consider all genes. All tests are performed on a whole genome platform. This makes it easy to start with a targeted analysis and automatically reflex up to a comprehensive analysis if the first test is non-diagnostic. No additional sample or sequencing is required.

Identity

NameVariantyx
Slugvariantyx
Type / kindstartup
Crunchbase IDvariantyx
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMa07YAKDA

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityTel Aviv-Yafo
HQ addressChaim Levanon Street 55, Tel Aviv-Yafo, Israel

Web & social

Websitehttps://www.variantyx.com
Careers pagehttps://www.variantyx.com/company/careers-benefits/
LinkedInhttps://www.linkedin.com/company/5378447
Twitter / Xhttps://twitter.com/variantyx
Facebookhttps://www.facebook.com/Variantyx

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftwareArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersLaboratoriesConsumersDemographics & FamilyWomen
Business models
B2BB2B2C
Tags
biopharmaceuticalpharma-companiespersonalizationprecision-medicineoncologynon-invasivepregnancypersonalized-medicinecancerclinical-datamedical-technologiesgenetic-disordershospitalsgenomicsdoctorsclinicslaboratoriesdiagnosticswomen-healthrare-diseasesdigital-healthcareartificial-intelligence

Funding

Total raised$131.5M
Current stageSeries D

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}